|
|
|
Mark Thompson - Canaccord/Adams
Clean Air Power Clean Air Power’s flagship technology is its patented Dual-FuelTM system, which enables heavy duty diesel engines to operate primarily on natural gas with diesel fuel acting as a “liquid spark plug.” By burning up to 90% natural gas, customers benefit from a combination of low emissions and high efficiency. With the increasing cost of diesel fuel, stringent emissions regulation and the need for a cleaner, quieter environment, Clean Air Power receives constant requests for its technological solutions and is currently developing a new generic Dual-FuelTM system for easy application to European trucks. This system is already undergoing vehicle trials on a DAF CF85 in the UK and is being installed on a Mercedes trial vehicle for a major supermarket retailer.
Futura Medical plc Futura Medical plc is a pharmaceutical products and medical device group that develops innovative products for the sexual healthcare market. The Company's shares are quoted on the Alternative Investment Market of the London Stock Exchange. We develop products aimed at the sexual well-being of healthy men and women and the treatment of sexual dysfunction. Our primary focus is on over-the-counter ("OTC") products with particular appeal to men and women who are reluctant to discuss potentially embarrassing sexual matters with their doctors. The three products under development are CSD500, FLD500 and MED2002. They are summarized here. CSD500 will be a condom to be used by healthy men. It incorporates an erectogenic compound which comes into contact with the penis on application of the condom. This is aimed at helping healthy men maintain an erection during intercourse in order to reduce condom slippage. FLD500 is a sister product to CSD500. For this product, the active compound will be applied to the outside of a condom thereby coming into direct contact with the vagina during sexual intercourse. This is aimed at helping healthy women maintain lubrication during intercourse, reducing the risk of condom failure. MED2002 will be a “rub-on” gel applied directly to the penis for the treatment of male erectile dysfunction. The Directors believe this will become the first pharmaceutical treatment for erectile dysfunction without the need of a doctor’s prescription. An exclusive agreement with SSL International plc, the maker of Durex™ condoms, has been signed to distribute both CSD500 and FLD500 globally when each product is licensed. The Group has entered into exclusive discussions with a major global pharmaceutical group on a proposed agreement for the worldwide development and marketing of MED2002
QuestAir Technologies Inc QuestAir is an emerging developer, manufacturer and supplier of advanced gas purification systems. Our products, which incorporate our patented fast-cycle pressure swing adsorption (“PSA”) technology, primarily target hydrogen purification in a range of existing industrial and energy markets, including oil refinery and gas processing applications, as well as emerging markets, such as fuel cell systems for distributed power generation and retail service stations which will provide hydrogen fuel for fuel cell powered vehicles. Our customers in the industrial gas, oil refining and chemical processing industries use our products for applications including hydrogen purification, hydrogen recovery, methane recovery from landfill gas and helium purification.
SubSea Resources SubSea Resources has been formed to salvage cargoes from cargo ships that have been lost in deep water. SubSea Resources has identified at least 70 commercial salvage targets and has identified twenty major target vessels containing cargoes with a gross value of over $450 million (based on recent LME metal prices and contemporary lading records). In the first phase of the company’s business plan it aims to raise the cargoes from six of these vessels over the next three years. In addition, it is anticipated that certain historic cargoes may be integrated with the commercial salvage operations. Some of the historic targets have potential values of many millions of dollars each, bringing the combined value of identified historic and commercial targets to well over $1 billion.
TEG Environmental Plc TEG was incorporated in October 1995
after purchasing the intellectual property of Dr Alan Heyworth, our Technical
Director and an acknowledged expert in thermophilic (high temperature)
composting.
|